LOVENOX 15 000 IU (150 mg)/1 ml, solution for injection in a pre-filled syringe 10 syringes of 1 ml
Brand page: Lovenox (enoxaparin sodium) — all forms and strengths in France
Active ingredients: ÉNOXAPARINE SODIQUE
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection10 syringes of 1 mlintraveineuse;sous-cutanée;voie extracorporelle autre
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LOVENOX 15 000 UI (150 mg)/1 ml, solution injectable en seringue préremplie
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse;sous-cutanée;voie extracorporelle autre
- Presentation description
- 10 seringues préremplies en verre de 1 mL avec système de sécurité ERISTM
- Marketing authorisation holder
- SANOFI WINTHROP INDUSTRIE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 25 Mar 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67118995CIP73019301CIP133400930193013Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉNOXAPARINE SODIQUEsolution | 15 000 UI anti-Xa (150 mg) · une seringue préremplie de 1 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.